# Alrex

NDC: 24208-353
Generic name: loteprednol etabonate
Labeler / Manufacturer: Bausch & Lomb Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 19980309

FDA application: NDA020803

## Active ingredients

- LOTEPREDNOL ETABONATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24208-353"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24208-353
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21c76da0-50a1-41c0-91b8-8cc4dcc27f60